Both Pfizer And GSK RSV Vaccines Set For Approval – But Could Next Readouts Give One The Edge?
Longer Term Data Ready Soon
Both vaccines look set for approval in time for the fall/winter RSV season, but broad uptake will depend on long-term data. • Source: Shutterstock 
